News Hub | News Direct

All Industries


Article thumbnail News Release

Nuestro Studios’ Dark Fantasy ‘El Clavito’ Goes into Production Starring Ruben Rabasa, Vivian Lamolli, and Alexander Arias

Brilla Media

Nuestro Studios, a division of Nuestro Stories, announced today that Ruben Rabasa (“I Think You Should Leave with Tim Robinson”), Vivian Lamolli (“Say a Little Prayer”), and comedy influencer Alexander Arias ( Mr. Red ) will star in their dark fantasy short, “El Clavito”. The bilingual film, the first in a slate of three planned films by Nuestro Studios, begins production in Miami this month and is being co-produced in partnership with CSP Media Group. “El Clavito” is the haunting story of a young couple who in the midst of a major home buying crisis are able to purchase a house from a mysterious elderly man for just $1 – and a strange condition that just might haunt them. “This story is an adaptation of a powerful sermon I first heard 30 years ago from my late pastor so I’m extremely honored this great cast and crew are joining me to produce a truly special, awesome story,” said Manuel Ruiz-Barrera, who will direct the film, and wrote the adapted screenplay. The film is being produced with a talented cast and production team that includes Mexican Americans, Puerto Ricans, Cubans, Colombians, Ecuadorians, and an Afro Latina lead actress. Nuestro Studios collaborated with Chicano Hollywood to find some of the actors who are joining the production. “El Clavito” will be ready for film festival season as of November, and will become the second major production completed by Nuestro Studios this year after the recent launch of this summer’s podcast series hit, “ Bistec ”. About Nuestro Stories Headquartered in Miami, Nuestro Stories is the flagship media brand of Brilla Media Ventures, and was founded with the premise of celebrating Latino heritage, history and origins every day. We provide engaging cultural content for multicultural marketers through our owned and operated platforms, Nuestro Stories, Nuestro Studios, and Brilla Latina. Our offerings also include programmatic advertising technology services for scalable media delivery, influencer marketing, creative studio services, and activations. Nuestro Stories is led by Angela Sustaita-Ruiz and Manuel Ruiz-Barrera, creators of Hispanicize, and trailblazers in the Hispanic media, social and influencer marketing industries, the Latino press release wire industry, and the first network of Hispanic print media companies online. Contact Details Rameh Echeverri +1 305-303-2322 Rameh@brillamedia.com

August 14, 2024 03:32 PM Eastern Daylight Time

Image
Article thumbnail News Release

Betterauds Celebrates 3000 Blog Posts with a Milestone Achievement in Entertainment and Inspirational Blogging

Rev Up Marketers

Betterauds.com is a forefront voice in the industry of entertainment and inspirational content. In the latest development, the company has proudly announced a momentous achievement: the publication of its 3000th blog post. Since its inception in 2019, this esteemed platform has become a cornerstone for compelling storytelling, offering readers an inside look into the lives of Celebrities, Musicians, Authors, Entrepreneurs, and other influential figures across the globe. This significant milestone underscores Betterauds.com's dedication to delivering a rich tapestry of content that resonates with diverse audiences. From in-depth profiles of notable personalities to exclusive interviews, the blog has cemented its reputation as a go-to source for captivating and inspiring content. With more than 1000 exclusive interviews, Betterauds.com has provided its audience with unparalleled insights into the personal and professional journeys of people who have made a substantial impact in their fields. Swati Sukhija Khattar, Co-Founder of Betterauds.com, expressed her excitement about the achievement, stating, "Our 3000th blog post is not just a testament to the tireless efforts of our team but also a celebration of the unwavering support from our readers. We are delighted to continue our mission of informing and inspiring our global audience with content that truly resonates." The blog's unique approach shines through in its focus on uplifting stories from individuals of varied backgrounds, including disabled persons, abuse survivors, U.S. veterans, and emerging entrepreneurs. By highlighting these narratives, Betterauds.com has established itself as a beacon of motivation and resilience, showcasing the human spirit in its most powerful form. In addition to its inspirational content, Betterauds.com offers a rich array of features for pop culture enthusiasts. Its extensive collection of articles on Celebrities, including detailed biographies and career highlights, allows fans to connect more deeply with their favorite stars. This personal touch adds a unique dimension to the blog's celebrity coverage, enhancing the reader's engagement with the content. Among its many achievements, Betterauds.com proudly boasts over 1000 interviews, reflecting its commitment to presenting diverse perspectives and valuable insights from around the world. These interviews not only highlight personal success stories but also offer a platform for voices that may otherwise remain unheard. The impact and quality of Betterauds.com's content have been recognized by major news outlets, further affirming the blog's influence in the entertainment and inspirational spheres. As it celebrates this landmark achievement, Betterauds.com remains committed to its mission of producing high-quality, engaging, and informative content. About the Company - Betterauds.com Founded in 2019, Betterauds.com is a premier entertainment blog dedicated to sharing the stories of Celebrities, Musicians, Authors, Entrepreneurs, YouTubers, and more. The blog focuses on illuminating the successes and inspirational journeys of individuals, making it a leading source for engaging and motivational content. Potential clients can visit the Betterauds.com for the latest updates and to explore the wealth of stories that Betterauds.com has to offer. Contact Details Betterauds Rajiv Khattar editor@betterauds.com Company Website https://betterauds.com/

August 14, 2024 11:29 AM Eastern Daylight Time

Image
Article thumbnail News Release

FitFast Develops Intermittent Fasting App Changing the Narratives of Health and Wellness Industry

Rev Up Marketers

FitFast is the pioneering force in health technology. In the recent development, the company has launched its groundbreaking app, designed to transform the world of intermittent fasting (IF). This innovative application harnesses the power of artificial intelligence (AI) to provide users with a highly personalized and adaptive approach to intermittent fasting, addressing the unique challenges and needs of individuals seeking to improve their health and well-being. Conceived by George Anderson, the visionary founder and CEO of FitFast, this advanced app marks a significant milestone in the intersection of technology and health. The development of FitFast reflects Anderson’s personal struggles with intermittent fasting, which highlighted a gap in the market for a tool that could offer more tailored and effective solutions. Intermittent fasting has garnered widespread acclaim over the past decade for its potential benefits, including weight loss, enhanced metabolic health, and increased longevity. However, many individuals encounter difficulties in successfully implementing fasting regimes. Challenges such as choosing the right fasting schedule, maintaining consistency, and monitoring progress often hinder the effectiveness of these plans. Traditional approaches to intermittent fasting frequently adopt a one-size-fits-all model, which fails to consider the diverse physiological and lifestyle factors of each individual. Enter FitFast is an app designed to overcome these limitations through its use of cutting-edge AI technology. The core of FitFast’s innovation lies in its ability to provide personalized fasting plans that adapt to users’ evolving needs. The app’s AI-driven algorithms analyze user data in real-time to offer customized recommendations and adjustments, ensuring that each fasting plan is uniquely suited to the individual’s progress and challenges. The FitFast experience begins with a comprehensive onboarding quiz that gathers crucial information about users’ lifestyles, preferences, and health goals. This initial assessment allows the app to craft a fasting plan that is not only effective but also sustainable over the long term. By addressing the specific needs and circumstances of each user, FitFast ensures a more engaging and achievable path to better health. Central to FitFast’s user experience is its AI-powered "Coach" feature, which offers real-time, personalized guidance through an intuitive conversational interface. This interactive element helps users stay on track with their fasting schedules, make informed decisions, and overcome obstacles. Additionally, FitFast includes a suite of tracking tools that monitor various health metrics such as weight, energy levels, and sleep patterns, providing users with valuable insights into their progress and allowing for timely adjustments. The integration of AI technology in FitFast represents a significant advancement in the wellness app market. The app’s AI system is designed to be both responsive and adaptive, learning from user interactions and continuously refining its recommendations. This dynamic interaction ensures that FitFast remains relevant and effective as users’ needs evolve over time, making intermittent fasting a viable and rewarding option for a broader audience. FitFast’s commitment to excellence is also reflected in its approach to user feedback. Prior to its official launch, the app underwent a closed beta testing phase, where a select group of users provided detailed feedback on their experiences. This beta testing phase was instrumental in refining the app’s features and functionality, ensuring a polished and effective final product. The development team remains dedicated to actively seeking user input, using this feedback to guide future updates and enhancements. Consequently, FitFast represents a new chapter in health and wellness, combining advanced technology with a personalized approach to intermittent fasting. With its innovative features and user-focused design, FitFast is set to redefine how individuals integrate fasting into their lives and achieve their health goals. About the Company - FitFast FitFast was founded by George Anderson, inspired by his own challenges with intermittent fasting and a vision to create a more effective and adaptable solution. The app brings together a team of experts dedicated to leveraging technology to improve health outcomes and simplify the fasting process. FitFast is committed to offering a transformative experience for users, making intermittent fasting a practical and rewarding endeavor. Intending users can visit the following link: https://www.fitfast.com/ for further details. Contact Details Fit Fast George Anderson +1 305-452-6789 press@fitfast.com Company Website https://www.fitfast.com/

August 14, 2024 11:18 AM Eastern Daylight Time

Image
Article thumbnail News Release

Notable Live Announces Partnership with NFL and Tennessee Titans Great, Chris “CJ2K” Johnson

Notable Live

Notable Live, a digital platform that facilitates exceptional fan experiences is today announcing that former NFL and Tennessee Titans running back Chris “CJ2K” Johnson has joined its team as a brand ambassador focused on athlete relations and outreach. Johnson joins the Notable Live team to introduce athletes to the platform and encourage current and former athletes to extend the fan experience beyond the playing field through in-person and virtual events, e-commerce offerings, and curated fan experiences. “Over the past year I’ve developed a meaningful relationship with the Notable Live team to connect with my fans, build a community, and help my legacy live on by sharing items from my playing days with my fans,” said Johnson. “I look forward to growing my relationship with Notable Live and sharing with some of my former teammates and colleagues the unique opportunity the platform provides.” “This is an exciting day for Notable Live. From day one, Chris utilized the Notable Live platform to create unique activation opportunities for his fans and quickly became an asset to our company,” said Mike Antonucci, co-founder and CEO of Notable Live. “We are thrilled to expand our relationship with Chris as a former player and now power user of the platform,” said Antonucci. “We look forward to what we can accomplish together and remain focused on bringing new and unique opportunities to the Notable Live community.” Fans can browse and bid on current inventory from Johnson and other NFL legends in the Notable Live on eBay Store ( https://www.ebay.com/str/notablelive ). About Notable Live Notable Live was co-founded in 2018 by fan Mike Antonucci and NFL Hall of Fame player Emmitt Smith to create a unique platform providing fans with unparalleled access to their favorite notables via virtual interactive events, in-person experiences, and curated e-commerce offerings. Notable Live has a mobile app available on the App Store and Google Play that puts fans “in the room” with their favorite notables for memorable virtual experiences. Connect with Notable Live at www.notable.live or on Instagram, Facebook or Twitter. Contact Details Notable Live Shannon Gross +1 318-537-2967 shannon.gross@notable.live Company Website https://www.notable.live/

August 14, 2024 09:00 AM Eastern Daylight Time

Article thumbnail Digital Asset Direct

News Direct's Ongoing Marketing Campaign Turns Its Focus to the Benefits of Its Unique In-platform Stakeholder Collaboration Tool

News Direct

Contact Details News Direct Media at News Direct sales@newsdirect.com Company Website http://www.newsdirect.com

August 14, 2024 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Panther Minerals Inc. (CSE: PURR) (OTC: GLIOF) Gears Up for Growth in the Uranium Revival

GLIOF

The uranium market is experiencing a remarkable resurgence as global energy strategies shift toward cleaner, more sustainable sources. Projected to reach $11.38 billion by 2030, the uranium sector is set to grow at an annual rate of over 5%, driven by increased reliance on nuclear energy and heightened climate goals. The rise in demand is fueled by major economies expanding their nuclear power capacities to cut carbon emissions and secure energy independence. In North America, this growth is evident as both established and new players in the uranium mining sector seek to meet the increasing global demand. This dynamic environment presents numerous opportunities for companies to explore and develop new uranium resources. As the market evolves, the focus now turns to how emerging companies are positioning themselves to take advantage of this booming industry. A Force in Uranium Exploration Panther Minerals Inc. (CSE: PURR) (OTC: GLIOF) is at the forefront of a revitalized uranium sector, poised to leverage the market’s impressive growth. The company is actively expanding its presence in North America with a focus on high-quality uranium projects, including its key assets: the Boulder Creek and Fireweed prospects. Fireweed Prospect: A Promising Uranium Discovery Panther Minerals has been particularly enthusiastic about its Fireweed Prospect, an exploration target located approximately 28 kilometers northwest of the Boulder Creek deposit. Discovered in 2006 by Triex Minerals Inc., the Fireweed Prospect has shown promising results, including a sample that returned 0.82% U3O8, indicating significant mineralization potential. Recent advancements include the use of advanced satellite imagery and hyperspectral analysis conducted by DIRT Exploration. This technology has provided valuable insights into mineral distribution and highlighted new exploration targets. The application of long-wave infrared (LWIR) and AI in mineral exploration is enhancing the company’s ability to pinpoint high-potential areas and refine their exploration strategies. “We are very positive about the satellite imagery attained from the DIRT Report, which gives us a more visual overview of the prospective Fireweed target on our Boulder Creek project. With ongoing historical compilation of data from the projects previous operators, adding updated materials through new technology will provide us crucial information as we advance future work programs,” stated Rob Birmingham, Chief Executive Officer of Panther Minerals. Boulder Creek Property: Building on Historical Data The Boulder Creek property, located in Alaska’s Seward Peninsula, continues to be a cornerstone of Panther Minerals' strategy. Historical drilling by previous operators has outlined a substantial uranium deposit, though the resource estimate is considered historical and not compliant with current NI 43-101 standards. The company is actively reviewing and analyzing existing data, with plans for comprehensive exploration including diamond drilling and geophysical surveys. Panther Minerals has made significant progress in securing permits for a five-year exploration program at Boulder Creek. The company has filed applications with both State and Federal authorities, including the US Bureau of Land Management (BLM) and the Alaska Department of Natural Resources (DNR). These permits will enable Panther to undertake a broad range of exploration activities and advance its development plans for the property. Strategic Expansion and Financial Position In addition to its current projects, Panther Minerals is expanding its portfolio through strategic acquisitions. The recent non-binding letter of intent to acquire the Huber Heights Uranium Property in Nevada demonstrates the company’s commitment to exploring underexplored regions with significant uranium potential. The property’s known prospects and historical production provide a solid foundation for future exploration. Financially, Panther Minerals has successfully closed a $2 million private placement, positioning itself well to fund exploration activities and advance its projects. The funds from this placement are earmarked for exploration and working capital, reinforcing the company’s ability to execute its growth strategy. Panther Minerals Inc. (CSE: PURR) (OTC: GLIOF) is well-positioned to capitalize on the growing uranium market. With a strong focus on high-potential properties, strategic acquisitions, and advanced exploration technologies, investors may want to take notice of the potential role Panther Minerals can play in the uranium resurgence. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website http://razorpitch.com

August 14, 2024 08:51 AM Eastern Daylight Time

Article thumbnail News Release

Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer

Benzinga

By Meg Flippin, Benzinga One in eight women will face a breast cancer diagnosis in the U.S. Of those, one in three will become metastatic. When breast cancer metastases, it often spreads to the bones, lungs or liver. Unfortunately, these tumors eventually become resistant to endocrine-blocking therapies and can reoccur in approximately 50% of patients. Depending on how much and far the cancer spreads, the five-year survival for distant metastatic breast cancer rate is 29%. The metastatic breast cancer treatment market is forecast to grow at a CAGR of 10.4% from 2021 to 2030, reaching $41.74 billion. With no direct cure in sight, keeping the cancer under control and increasing survival rates are the focus areas of biopharmaceutical companies, big and small, including Oncolytics Biotech Inc. (NASDAQ: ONCY). The clinical-stage biopharmaceutical company specializing in immunotherapeutics for oncology and their leading agent pelareorep, has demonstrated promising results in Phase 1 and 2 studies to fight challenging cancers. When pelareorep was added to standard metastatic breast cancer treatment, overall survival rates nearly doubled in a randomized study of patients with HR+/HER2- breast cancer, reports Oncolytics. Pelareorep is an intravenously delivered immunotherapeutic agent that induces anti-cancer immune responses and promotes an inflamed tumor phenotype — turning “cold” tumors “hot.” Pelareorep works by generating, recruiting and training immune cells to recognize and kill cancer while remodeling the tumor microenvironment to enable immune cell access. When added to existing treatment regimens such as chemotherapy, pelareorep demonstrates the potential to extend survival times in addition to expanding existing and new T cell clones in the blood, the company reports. Proving Its Mettle In Oncolytics’ randomized Phase 2 trials, known as BRACELET-1, pelareorep demonstrated meaningful improvements in overall response rate and progression-free survival. Overall survival from this trial continues to mature. A previous randomized phase 2 trial also showed positive results, including a statistically significant near doubling of median overall survival observed. Data from BRACELET-1 and AWARE-1 studies consistently show that pelareorep produces an expansion of T cell clones and/or an increase in CelTIL scores and peripheral tumor-infiltrating lymphocyte counts, reports the company. The trials also demonstrated a manageable safety profile which is consistent with prior studies. Positive data from BRACELET-1 and IND-213 randomized trials showed meaningful clinical improvements in the pelareorep/paclitaxel combination arms compared to paclitaxel monotherapy, says Oncolytics. Multiple patients in the pelareorep/paclitaxel arm continue to be followed for survival, with overall survival results expected in the second half of the year. “We believe this data will further bolster our compelling data package and underscores the therapeutic potential of pelareorep,” said Wayne Pisano, interim CEO and chair of the board of Oncolytics. “We remain committed to improving the standard of care and addressing the high unmet medical needs of these patients.” Working Hand-In-Hand With The FDA Pelareorep has fast track designation from the Food and Drug Administration, which allows for the expedited review of drugs for serious conditions that need novel treatments. Oncolytics was also recently part of a productive Type C meeting with the FDA to support the planned potential registration-enabling trial for pelareorep in HR+/HER2- metastatic breast cancer (mBC). Oncolytics said the FDA supports progression-free survival as the primary endpoint of the study, with overall survival as a key secondary endpoint. The company’s proposed study will enroll patients for whom hormonal therapy hasn’t worked and who have received no more than one line of antibody-drug conjugate (ADC) therapy. “Aligning with the FDA on key design elements and objectives of our planned registrational trial for pelareorep marks a critical step towards bringing this innovative treatment to patients,” said Thomas Heineman, M.D., Ph.D., Chief Medical Officer at Oncolytics. “Our de-risked program builds on compelling data and key learnings from two randomized studies, BRACELET-1 and IND-213, which demonstrated clinically meaningful benefit in patients receiving pelareorep and paclitaxel compared to paclitaxel alone. Additionally, translational data from the AWARE-1 study highlights pelareorep’s immune-mediated mechanism of action in breast cancer patients. We are now well-positioned to deliver on our mission of making pelareorep available to breast cancer patients in need of better treatment options,” he said. Breast cancer is common, and while many cases are treatable, metastatic breast cancer is a different story. At stage 4, the tumors have spread to other parts of the body and recurrence is frequent. Extending the survival rate is the name of the game, and Oncolytics thinks it has a winner with pelareorep. With clinical trials demonstrating pelareorep’s potential under its belt and a big one in the works, Oncolytics may be right. Featured photo by Susan G. Komen 3-Day on Unsplash Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 14, 2024 08:45 AM Eastern Daylight Time

Image
Article thumbnail News Release

News Direct Unveils TradeUp Powered by Instinct

News Direct

News Direct proudly announces the launch of TradeUp, a cutting-edge new media outreach solution powered by Instinct, poised to transform trade media dissemination and engagement. For years, newswire users have faced difficulty in effectively connecting with trade journalists due to a reliance on ill-suited methods of outreach — choosing broad industry verticals and sending press releases to generic lists of publications and anonymous writers. The most common result has been an inability to determine if journalists are engaging with their content. TradeUp, empowered by Instinct’s innovative AI technology, represents a groundbreaking advancement in media outreach. TradeUp removes the guesswork and inefficiency offered by legacy newswires by offering a laser-focused, data-driven approach. TradeUp, allows issuers to move past generic media lists and instead begin engaging with journalists who have a genuine interest in, and have recently written about, their industry news. Key Features of TradeUp Include: Precise Journalist Identification: Instinct's AI instantaneously scans millions of articles in real-time, identifying and delivering key details about journalists, including contact information, beat, publication, recently published articles and even the Domain Ranking of the publishers' websites. This ensures news reaches the appropriate targets and enables interaction with individual journalists, thereby boosting the chances for earned coverage. Automated Pitching: Send personalized pitches directly from the Instinct platform, streamlining media relations efforts and making it easier to connect with the most relevant journalists. Reach More Than Just Trade Journals: The capabilities of TradeUp extend beyond solely vertical industry publications. The platform will generate data from reporters from a wide range of media outlets, from newspapers to broadcast stations, broadening the outreach footprint and increasing the chance to earn meaningful coverage. Elevates Trade Media Outreach Strategy TradeUp lets News Direct customers experience the new era of trade media engagement that uses an AI-driven approach to simplify the media targeting process and amplify the message by matching content with the appropriate journalists with the precision, speed and efficiency that only AI can deliver. About News Direct News Direct is a technology-driven content distribution and amplification platform for PR, IR, corporate communications and marketing professionals. Our automated platform delivers a completely reimagined, modernized user experience for newswire users that has reshaped the industry landscape. Additionally, the company has expanded its offerings to include an array of technology-enhanced message amplification tools ranging from sponsored content to podcasting products, all from a single online destination. Contact Details News Direct Gregg Castano, CEO +1 917-698-4131 gregg.castano@newsdirect.com Company Website http://www.newsdirect.com

August 14, 2024 08:45 AM Eastern Daylight Time

Image
Article thumbnail News Release

Maxim Group Initiates Coverage Of Brand Engagement Network (NASDAQ: BNAI) With Buy Rating, Sets Over 100% Higher Price Target

Benzinga

By Anthony Termini, Benzinga Investment firm Maxim Group initiated research coverage of Brand Engagement Network (NASDAQ: BNAI), or BEN, last week. BEN is a provider of conversational GENAI technology that provides human-like avatars that interface with consumers for enhanced experiences. Conversational artificial intelligence (AI) has the ability to recognize, translate, predict and respond to a given customer’s written or spoken input. BEN is regarded as a leader in creating personalized AI experiences. Maxim Group Analyst Sees Unique Opportunity In Marketplace And BEN’s Business Model According to Jack Vander Aarde, a senior equity research analyst at Maxim Group, “BEN has emerged as a pure-play conversational AI company.” In its research report dated July 25, 2024, Maxim initiated coverage of BEN with a buy rating. The report notes that BEN delivers a full-stack turnkey offering to businesses looking to improve productivity, performance metrics and consumer experiences. It goes on to say that, “The proliferation of generative AI is being driven by the pursuit of cost reduction, value enhancement, differentiated customer engagements, and operational efficiency benefits.” Citing various sources, Maxim notes that the total addressable market (TAM) for generative AI is expected to exceed $30 billion by 2030. It also says that 94% of large companies using generative AI anticipate integrating voice into it within the next two years. Maxim’s growth outlook for BEN is further supported by a recent infusion of significant growth capital from existing investors. Research Report Provides Detail On BEN’s Operating Strengths Maxim Group’s research report focuses on BEN’s significant market opportunities in two specific verticals; the automotive industry and healthcare. In the automotive space, Maxim points out that BEN recently signed a five-year exclusive partnership with Automotive Financial Group (AFG). The deal leverages AFG’s ability to put BEN’s AI technology in front of more than 450,000 auto dealers, service centers and insurance carriers around the world. Maxim believes the deal could represent up to $45 million in recurring annual revenue for BEN. The firm also noted that AFG has made a commitment to invest roughly $6.5 million in BEN over the next four years. This “serves as a stamp of credibility and reinforces our confidence in [BEN]’s AI technology, capabilities, and leadership team,” the report said. The other sales channel noted in Maxim’s report was the healthcare industry, where BEN has recently made significant operational strides. The company recently achieved compliance with the Health Insurance Portability and Accountability Act (HIPAA) and SOC 2 Type 1 certification, which demonstrate its ability to meet the highest requirements for the secure handling of sensitive patient data. The report also points out that Brand Engagement Network recently entered into three healthcare pilot programs. They include OSF HealthCare, Weill Cornell Medical Center and MedAdvisor Solutions, which is based in Camberwell, Australia. Maxim says that the pilot programs could represent about $1 million in annual contract value and that the affiliation with MedAdvisor Solutions gives BEN access to some 37,000 pharmacies worldwide. More broadly, the healthcare vertical represents more than 145,000 potential customers, including hospitals, outpatient and urgent care facilities, physician group locations and dental offices. Maxim’s Valuation Metrics And Revenue Expectations Offer Insight To Price Target According to the Maxim Group research report, BEN’s stock trades at a discount to its peers based on enterprise-value-to-revenue multiples. It suggests that the stock should trade at a premium, which it justifies by BEN’s “significant early-stage TAM opportunities and our robust growth outlook.” The investment firm projects BEN will achieve strong growth and positive adjusted EBITDA by 2027. It expects BEN’s annual recurring revenue to ramp up next year and that growth will accelerate through 2028. Brand Engagement Network’s common stock has recently traded around $3.00 per share. Maxim set a price target of $6.00. Investment Risks Discussed By The Analyst The report notes that BEN is still “a pre-revenue company.” As a result, the firm assigned it a “Speculative Risk Profile” based on fundamental criteria. The risk rating applies to early-stage companies with minimal to no revenues, lack of earnings, balance sheet concerns and/or a short operating history. Speculative stocks may not be suitable for a significant class of individual investors. But for those with an otherwise well diversified portfolio and appropriate risk tolerance, BEN might be worthy of further review. Featured photo by TreptowerAlex from Pixabay. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 14, 2024 08:35 AM Eastern Daylight Time

Image
1 ... 8788899091 ... 3773